Literature DB >> 4166

Adjuvant and immunostimulating activities of water-soluble substances extracted from Mycobacterium tuberculosis (var. hominis).

G H Werner, R Maral, F Floch, D Migliore-Samour, P Jollès.   

Abstract

Water-soluble substances have been extracted from two strains of Mycobacterium tuberculosis var. hominis: the native hydrosoluble part (polysaccharide and peptidoglycan), a substance in which the polysaccharide moiety is less abundant than in the latter, the acetylated peptidoglycan and, finally a tetrasaccharide-heptapeptide. All four types of substances, when they were injected together with Freund's incomplete adjuvant, exerted an adjuvant effect on the production of delayed-type hypersensitivity to ovalbumin in the guinea pig and on the production of anti-influenza virus antibodies in the rabbit. Injected intravenously in the mouse, they increased the number of antibody-producing cells in the spleen and enhanced the graft versus host reaction; no effect was seen on the phagocytic activity of the reticulo-endothelial system. By contrast with wax D, the water-soluble substances were devoid of arthritis-inducing activity in the rat. Altogether, these water-soluble substances seem to be endowed with at least some of the adjuvant activities of Freund's complete adjuvant and some of the immunostimulant activities of a live Mycobacterium like BCG.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 4166

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  7 in total

1.  Hydrosoluble immunostimulants of bacterial and synthetic origins.

Authors:  P Jollès
Journal:  Experientia       Date:  1976-06-15

2.  Adjuvant effect of a peptidoglycan attached covalently to a synthetic antigen provoking anti-phage antibodies.

Authors:  H Langbeheim; R Arnon; M Sela
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

3.  Adjuvant activities of chemically modified water-soluble substances from Mycobacterium tuberculosis.

Authors:  D Migliore-Samour; F Floc'h; R Maral; G H Werner; P Jollès
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

4.  An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.

Authors:  Basavaraj Binjawadagi; Varun Dwivedi; Cordelia Manickam; Kang Ouyang; Jordi B Torrelles; Gourapura J Renukaradhya
Journal:  Int J Nanomedicine       Date:  2014-03-24

5.  Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs.

Authors:  Varun Dwivedi; Cordelia Manickam; Ruthi Patterson; Katie Dodson; Matthew Weeman; Gourapura J Renukaradhya
Journal:  Vaccine       Date:  2011-04-09       Impact factor: 3.641

6.  Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.

Authors:  Varun Dwivedi; Cordelia Manickam; Ruthi Patterson; Katie Dodson; Michael Murtaugh; Jordi B Torrelles; Larry S Schlesinger; Gourapura J Renukaradhya
Journal:  Vaccine       Date:  2011-04-03       Impact factor: 3.641

7.  Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.

Authors:  Basavaraj Binjawadagi; Varun Dwivedi; Cordelia Manickam; Kang Ouyang; Yun Wu; Ly James Lee; Jordi B Torrelles; Gourapura J Renukaradhya
Journal:  Int J Nanomedicine       Date:  2014-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.